1Oudit G Y,Kassiri Z,Sah R,et al.The molecular physiology of the cardiac transient outward potassium current (Ito) in normal and diseased myocardium[J].J Mol Cell Cardiol,2001,33:851-872.
2Tsuchiya T,Ashikaga K,Honda T,et al.Prevention of ventricular fibrillation by cilostazol,an oral phosphodiesterase inhibitor,in a patient with brugada syndrome[J].J Cardiovasc Electrophysiol,2002,13:698-701.
3Xiao G S,Zhou J J,Cheung Y F,et al.Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes[J].Eur J Pharmacol,2003,473:97-103.
4Tani T,Uehara K,Sudo T,et al.Cilostazol,a selective type III phosphodiesterase inhibitor,decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats[J].Atherosclerosis,2000,152:299-305.
